TSS Clinical Trials Digitalization User Forum 2021
Document
We’re pleased to announce the first TSS Clinical Trials Digitalization User Forum on February 10-11, 2021
How can digitalization transform trials while maintaining quality standards that ensure safe medicine?
What is on this page?
Click to jump to a specific section below.
Digitalization to transform clinical trials to ensure a safe drug to every patient
Together with our most valued partners, we are hosting two half-day virtual sessions with interactive content addressing value-adding digital transformation in clinical trials.
This by-invitation-only user forum set out to discuss best practices for streamlining clinical trial costs and efforts by utilizing digital technologies while moving more towards a patient-centered trial experience.
Some of the topics discussed during the forum were:
- Leveraging IoT to transform clinical trials and lower costs in 2021
- Ensuring a safe drug to every patient with Digital health and Remote inspections
- Creating a holistic end-to-end view that drives sustainability and reduces waste
- Transforming the future. New solutions available
In case you would like to get more information about the event, please contact us.
You may also be interested in
Meet our people: Quality Engineer, Akanksha Sharma
Akanksha Sharma joined TSS in 2021 as a Quality Engineer in our Validation team, where she helped make sure our systems and processes are working exactly as they should. Always keen to continue expanding her skills and experience, in 2022 Akanksha took on a new challenge within our company.
Read moreDownload Whitepaper.avif)
TSS Welcomes Thomas Lindén as New Chief Technology Officer
TSS, a leading temperature monitoring solutions provider, is pleased to announce the appointment of Thomas Lindén as its new Chief Technology Officer (CTO). In this role, Thomas Lindén will play a crucial part in shaping the company's technological landscape and driving its growth strategies.
Read moreDownload Whitepaper
What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read moreDownload WhitepaperYou may also be interested in
Join Us at Clinical Trial Supply East Coast US
TSS is proud to sponsor Clinical Trial Supply East Coast 2026, on November 4–5 in King of Prussia, Pennsylvania, US.
Read more
How To Minimise the Environmental Impact of Cloud Operations
When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more